Resultados de la búsqueda 641-650 of 4093 for live vaccines

  1. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    This study does not involve experimental treatment of any ocular tumor, but rather observation of tumor natural history or outcomes following standard of care ...

  2. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    There is a need for new treatments for myelofibrosis (MF) patients based on laboratory insight into disease pathogenesis. We will use primary patient samples to ...

  3. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    There is a need for new treatments for myelofibrosis (MF) patients based on laboratory insight into disease pathogenesis. We will use primary patient samples to ...

  4. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    This partially randomized clinical trial studies cholecalciferol in improving survival in patients with newly diagnosed cancer with vitamin D insufficiency.

  5. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Rochester, Minn. The purpose of this study is to see if different depths of submucosal tumor invasion in esophageal cancer can predict lymph node involvement ...

  6. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Borderline Resectable Pancreatic Cancer - Tumor-vessel interface ≥180° of vessel wall circumference, and/or reconstructible occlusion of the SMV-PV. - Tumor- ...

  7. La infección por el VPH: ¿una causa de cáncer en hombres? - Mayo Clinic

    https://www.cdc.gov/std/hpv/stdfact-hpv-and-men.htm. Accessed March 19, 2024. AskMayoExpert. Human papillomavirus (HPV) vaccination. Mayo Clinic; 2022. HPV ...

  8. Médicos - Medicina de laboratorio y patología - Mayo Clinic

    Md Shahrier Amin, M.B.B.S., Ph.D. Jacksonville, FL. Marie-Christine Aubry, M.D.. Rochester, MN.

  9. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Borderline Resectable Pancreatic Cancer - Tumor-vessel interface ≥180° of vessel wall circumference, and/or reconstructible occlusion of the SMV-PV. - Tumor- ...

  10. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Ibrutinib may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. Rituximab is a monoclonal antibody that may interfere with ...